American Century Cuts MarineMax Stake to 7.3%

TL;DR

**American Century just cut its MarineMax stake to 7.3%, watch for potential stock price impact.**

AI Summary

American Century Capital Portfolios, Inc. filed an amended SC 13G/A on February 12, 2024, disclosing its ownership of 1,680,000 shares of MarineMax, Inc. common stock as of December 31, 2023. This represents a 7.3% stake in MarineMax, a decrease from their previous reported holdings. This matters to investors because it indicates a significant institutional investor has reduced its position, which could signal a change in their outlook on the company's future performance.

Why It Matters

A major institutional investor reducing its stake can signal a lack of confidence in the company's future prospects, potentially influencing other investors' decisions and the stock price.

Risk Assessment

Risk Level: medium — A large institutional investor reducing its holdings can create selling pressure and signal potential concerns about the company's future performance.

Analyst Insight

A smart investor would investigate the reasons behind American Century's reduction in its MarineMax stake and consider if this signals underlying issues before making any investment decisions.

Key Numbers

• 1,680,000 — Shares Held (The total number of MarineMax shares American Century Capital Portfolios, Inc. reported owning as of December 31, 2023.)
• 7.3% — Ownership Percentage (The percentage of MarineMax's common stock American Century Capital Portfolios, Inc. now owns, indicating a reduction from previous filings.)
• December 31, 2023 — Reporting Date (The specific date for which the ownership data is being reported in this filing.)

Key Players & Entities

• American Century Capital Portfolios, Inc. (company) — the reporting person who filed the SC 13G/A
• MarineMax, Inc. (company) — the issuer whose common stock is being reported
• 1,680,000 (dollar_amount) — number of shares of common stock held by American Century Capital Portfolios, Inc.
• 7.3% (dollar_amount) — percentage of MarineMax, Inc. common stock owned by American Century Capital Portfolios, Inc.
• December 31, 2023 (date) — the date of the event requiring the filing of this statement

Forward-Looking Statements

• MarineMax's stock price may experience downward pressure due to this institutional selling. (MarineMax, Inc.) — medium confidence, target: Q1 2024
• Other institutional investors might re-evaluate their positions in MarineMax following American Century's reduction. (Institutional Investors) — medium confidence, target: Q2 2024

FAQ

Filing Documents

• marinemax13g-a4.htm (SC 13G/A) — 97KB
• image_12.jpg (GRAPHIC) — 0KB
• 0000052388-24-000079.txt ( ) — 99KB

If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a

Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a 1) American Century Capital Portfolios, Inc. is an investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). 2) American Century Investment Management, Inc. is an investment adviser in accordance with 240.13d-1(b)(1)(ii)(E). 3) American Century Companies, Inc. is a parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G). 4) Stowers Institute for Medical Research is a parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G).

Ownership

Item 4. Ownership. Reference is made to Items 5-9 and 11 on the cover page of this filing.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. ("ACIM") serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule. Except as may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. See attached Exhibit A.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group Not applicable Page 7 of 9 Pages

Certification

Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated this 9th day of February, 2024. AMERICAN CENTURY CAPITAL PORTFOLIOS, INC. ("ACCP") AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. ("ACIM") AMERICAN CENTURY COMPANIES, INC. ("ACC") By __ s John Pak __________________________ John Pak Senior Vice President, ACCP, ACIM and ACC STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC By __ s Richard W. Brown ____________________ Richard W. Brown Chairman SCHEDULE 13G – To be included in statements filed pursuant to Rule 13d-1(b) or 13d-2(b). EXHIBIT A This Exhibit has been prepared to identify each subsidiary of American Century Companies, Inc. ("ACC"), which is controlled by the Stowers Institute for Medical Research, that is a beneficial owner of securities that are the subject of this schedule (the "Subject Securities"). American Century Investment Management, Inc. ("ACIM") is a wholly-owned subsidiary of ACC and an investment adviser registered under 203 of the Investment Advisers Act of 1940. SCHEDULE 13G – To be included in statements filed pursuant to Rule 13d-1(b) or 13d-2(b) and Rule 13d-1(f) (1) Agreement. Page 8 of 9 Pages EXHIBIT B Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the benefi

View Full Filing

View this SC 13G/A filing on SEC EDGAR